ClinicalTrials.Veeva

Menu

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

NYU Langone Health logo

NYU Langone Health

Status and phase

Completed
Phase 2

Conditions

Primary Progressive Aphasia

Treatments

Behavioral: Word-Naming Activity
Device: Transcranial Direct Current Stimulation (tDCS)

Study type

Interventional

Funder types

Other

Identifiers

NCT05615922
22-01155

Details and patient eligibility

About

The purpose of this study is to establish the feasibility of a program of remotely supervised transcranial direct current stimulation (RS-tDCS) paired with language skills practice for people living with the semantic or logopenic variants of primary progressive aphasia (PPA). There are currently no established standard-of-care treatments for PPA. This study will evaluate whether RS-tDCS combined with language skills practice is a feasible study design for individuals with PPA.

Enrollment

11 patients

Sex

All

Ages

45 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Primary progressive aphasia diagnosis (logopenic or semantic variant)
  2. Peabody Picture Vocabulary Test (PPVT) score < -1.0 SD, serving as a literacy proxy for premorbid cognitive ability and ensuring English language fluency sufficient for participation in the study procedures.
  3. WAIS-IV Matrix Reasoning T score < 20, serving as an index of current general cognitive functioning to exclude those with severe cognitive impairment
  4. Stable and continuous access to internet service, email (WiFi "hotspot" to be provided if needed)
  5. Fluent in English language (due to outcomes validated in English versions only)

Exclusion criteria

  1. Disorder other than PPA known to cause language dysfunction
  2. Diagnosis of nonfluent/agrammatic subtype of primary progressive aphasia
  3. History of traumatic brain injury
  4. Uncontrolled seizure disorder and/or recent (<5 years) history of seizure
  5. Metal implants in the head or neck
  6. Any skin disorder or skin sensitive area near stimulation locations
  7. Pregnant or breastfeeding

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

11 participants in 1 patient group

Remotely Supervised tDCS and Word-Naming Practice
Experimental group
Description:
At each session, the tDCS device will deliver 2.0 mA electric current for 30 minutes over the left frontotemporal lobe with focus on the inferior frontal gyrus (IFG). Participants will receive 20 intervention sessions over the course of the interventional period (4 weeks) on weekdays (Monday-Friday). During the stimulation period, participants will engage in a picture-naming exercise as guided by the study tDCS clinicians.
Treatment:
Device: Transcranial Direct Current Stimulation (tDCS)
Behavioral: Word-Naming Activity

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Matthew Lustberg; Eric McConathey

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems